-
Jianjun
Pan,
Qiang
Chen,
D.
Willenbring,
D.
Mowrey,
X.
Kong,
A.
Cohen,
Christopher
Divito,
Yan
Xu,
P.
Tang
(2012)
Structure of the pentameric ligand-gated ion channel GLIC bound with anesthetic ketamine.
Structure, 20 9
-
Proc Natl Acad Sci
-
J.
Renaud,
N.
Rochel,
M.
Ruff,
V.
Vivat,
P.
Chambon,
H.
Gronemeyer,
D.
Moras
(1995)
Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.
Nature, 378 6558
-
A.
Parent,
J.
Gunther,
J.
Katzenellenbogen
(2008)
Blocking estrogen signaling after the hormone: pyrimidine-core inhibitors of estrogen receptor-coactivator binding.
Journal of medicinal chemistry, 51 20
-
S.
Fleishman,
J.
Schlessinger,
N.
Ben-Tal
(2002)
A putative molecular-activation switch in the transmembrane domain of erbB2
Proceedings of the National Academy of Sciences of the United States of America, 99
-
D.
Fabbro,
S.
Cowan-Jacob,
Henrik
Möbitz,
G.
Martiny-Baron
(2012)
Targeting cancer with small-molecular-weight kinase inhibitors.
Methods in molecular biology, 795
-
Johannes
Antony,
K.
Kellershohn,
Marion
Mohr-Andrä,
A.
Kebig,
S.
Prilla,
M.
Muth,
E.
Heller,
T.
Disingrini,
C.
Dallanoce,
S.
Bertoni,
J.
Schrobang,
C.
Trankle,
E.
Kostenis,
A.
Christopoulos,
H.
Höltje,
E.
Barocelli,
M.
Amici,
U.
Holzgrabe,
K.
Mohr
(2009)
Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity
The FASEB Journal, 23
-
V.
Hindié,
Adriana
Stroba,
Huan
Zhang,
Laura
Lopez-Garcia,
L.
Idrissova,
S.
Zeuzem,
D.
Hirschberg,
F.
Schaeffer,
T.
Jørgensen,
M.
Engel,
P.
Alzari,
R.
Biondi
(2009)
Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1.
Nature chemical biology, 5 10
-
R.
Bruns,
J.
Fergus
(1990)
Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes.
Molecular pharmacology, 38 6
-
S.
Hubbard
(1997)
Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog
The EMBO Journal, 16
-
T.
Geistlinger,
A.
McReynolds,
R.
Guy
(2004)
Ligand-selective inhibition of the interaction of steroid receptor coactivators and estrogen receptor isoforms.
Chemistry & biology, 11 2
-
A.
Christopoulos,
T.
Kenakin
(2002)
G Protein-Coupled Receptor Allosterism and Complexing
Pharmacological Reviews, 54
-
H.
Hanchar,
Panida
Chutsrinopkun,
P.
Meera,
P.
Supavilai,
W.
Sieghart,
M.
Wallner,
R.
Olsen
(2006)
Ethanol potently and competitively inhibits binding of the alcohol antagonist Ro15-4513 to α4/6β3δ GABAA receptors
Proceedings of the National Academy of Sciences of the United States of America, 103
-
B.
Fredholm,
A.
IJzerman,
K.
Jacobson,
J.
Linden,
C.
Müller
(2011)
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
Pharmacological Reviews, 63
-
M.
Sanders,
Zahabia
Ali,
B.
Hegarty,
R.
Heath,
M.
Snowden,
D.
Carling
(2007)
Defining the Mechanism of Activation of AMP-activated Protein Kinase by the Small Molecule A-769662, a Member of the Thienopyridone Family*
Journal of Biological Chemistry, 282
-
R.
Dror,
Hillary
Green,
C.
Valant,
D.
Borhani,
James
Valcourt,
Albert
Pan,
Daniel
Arlow,
M.
Canals,
J.
Lane,
Raphaël
Rahmani,
J.
Baell,
P.
Sexton,
A.
Christopoulos,
D.
Shaw
(2013)
Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs
Nature, 503
-
M.
Kjelsberg,
Susanna
Cotecchia,
Jacek
Ostrowski,
M.
Caron,
R.
Lefkowitz
(1992)
Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation.
The Journal of biological chemistry, 267 3
-
D.
Colquhoun
(1973)
The Relation between Classical and Cooperative Models for Drug Action
-
D.
Kojetin,
T.
Burris
(2014)
REV-ERB and ROR nuclear receptors as drug targets
Nature Reviews Drug Discovery, 13
-
A.
Kornev,
N.
Haste,
Susan
Taylor,
L.
Eyck
(2006)
Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism
Proceedings of the National Academy of Sciences, 103
-
R.
Olsen,
W.
Sieghart
(2009)
GABAA receptors: Subtypes provide diversity of function and pharmacology
Neuropharmacology, 56
-
J.
Pike,
P.
Pathrose,
O.
Barmina,
Ching-Yi
Chang,
D.
McDonnell,
Hironori
Yamamoto,
N.
Shevde
(2003)
Synthetic LXXLL peptide antagonize 1,25‐dihydroxyvitamin D3‐dependent transcription
Journal of Cellular Biochemistry, 88
-
S.
Vernino,
M.
Amador,
C.
Luetje,
J.
Patrick,
J.
Dani
(1992)
Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors
Neuron, 8
-
W.
Schmalhofer,
Jeffrey
Calhoun,
R.
Burrows,
Timothy
Bailey,
M.
Kohler,
A.
Weinglass,
G.
Kaczorowski,
Maria
Garcia,
M.
Koltzenburg,
B.
Priest
(2008)
ProTx-II, a Selective Inhibitor of NaV1.7 Sodium Channels, Blocks Action Potential Propagation in Nociceptors
Molecular Pharmacology, 74
-
Alison
Abbott,
Eric
Barnard,
Tom
Bonner,
Phillip
Bradley,
G.
Cosmides,
B.
Dhawan,
P.
Vanhoutte
(1994)
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification.
Pharmacological reviews, 46 2
-
T.
Kute,
C.
Lack,
M.
Willingham,
Bimjhana
Bishwokama,
H.
Williams,
K.
Barrett,
Tanita
Mitchell,
J.
Vaughn
(2004)
Development of Herceptin resistance in breast cancer cells
Cytometry Part A, 57A
-
C.
Mulle,
C.
Léna,
J.
Changeux
(1992)
Potentiation of nicotinic receptor response by external calcium in rat central neurons
Neuron, 8
-
Yun
Weng,
Liya
Yang,
P.
Corringer,
J.
Sonner
(2010)
Anesthetic Sensitivity of the Gloeobacter violaceus Proton-Gated Ion Channel
Anesthesia & Analgesia, 110
-
J.
Renaud,
N.
Rochel,
M.
Ruff,
V.
Vivat,
P.
Chambon,
H.
Gronemeyer,
D.
Moras
(1995)
Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid
Nature, 378
-
C.
Lindsley,
Zhijian
Zhao,
W.
Leister,
R.
Robinson,
S.
Barnett,
D.
Defeo-jones,
Raymond
Jones,
G.
Hartman,
J.
Huff,
H.
Huber,
M.
Duggan
(2005)
Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors.
Bioorganic & medicinal chemistry letters, 15 3
-
K.
Guertin,
J.
Grimsby
(2006)
Small molecule glucokinase activators as glucose lowering agents: a new paradigm for diabetes therapy.
Current medicinal chemistry, 13 15
-
T.
Steinfeld,
M.
Mammen,
Jacqueline
Smith,
Richard
Wilson,
J.
Jasper
(2007)
A Novel Multivalent Ligand That Bridges the Allosteric and Orthosteric Binding Sites of the M2 Muscarinic Receptor
Molecular Pharmacology, 72
-
R.
Neubig,
M.
Spedding,
T.
Kenakin,
A.
Christopoulos
(2003)
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology
-
Q.
Tan,
Ya
Zhu,
Jian
Li,
Zhuxi
Chen,
G.
Han,
I.
Kufareva,
Tingting
Li,
Limin
Ma,
G.
Fenalti,
Jing
Li,
Wenru
Zhang,
Xin
Xie,
H.
Yang,
Hualiang
Jiang,
V.
Cherezov,
Hong
Liu,
R.
Stevens,
Qiang
Zhao,
Beili
Wu
(2013)
Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex
Science, 341
-
A.
Levitzki
(2003)
Protein kinase inhibitors as a therapeutic modality.
Accounts of chemical research, 36 6
-
Clay
Armstrong
(1974)
Ionic pores, gates, and gating currents
Quarterly Reviews of Biophysics, 7
-
A.
Brzozowski,
A.
Pike,
Z.
Dauter,
R.
Hubbard,
T.
Bonn,
O.
Engström,
L.
Öhman,
G.
Greene,
J.
Gustafsson,
M.
Carlquist
(1997)
Molecular basis of agonism and antagonism in the oestrogen receptor
Nature, 389
-
D.
Jenkinson,
E.
Barnard,
D.
Hoyer,
P.
Humphrey,
P.
Leff,
N.
Shankley
(1995)
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology.
Pharmacological reviews, 47 2
-
Yunkun
Wu,
Yi
Yang,
S.
Ye,
Youxing
Jiang
(2010)
Structure of the Gating Ring from the Human High-conductance Ca2+-gated K+ Channel
Nature, 466
-
O.
Arunlakshana,
Schild
Ho
(1997)
SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
British Journal of Pharmacology, 120
-
J.
Changeux
(2012)
Allostery and the Monod-Wyman-Changeux model after 50 years.
Annual review of biophysics, 41
-
P.
Tummino,
R.
Copeland
(2008)
Residence time of receptor-ligand complexes and its effect on biological function.
Biochemistry, 47 20
-
A.
Galande,
K.
Bramlett,
J.
Trent,
T.
Burris,
J.
Wittliff,
A.
Spatola
(2005)
Potent Inhibitors of LXXLL‐Based Protein–Protein Interactions
ChemBioChem, 6
-
J.
Payandeh,
T.
Scheuer,
Ning
Zheng,
W.
Catterall
(2011)
THE CRYSTAL STRUCTURE OF A VOLTAGE-GATED SODIUM CHANNEL
Nature, 475
-
H.
Hamm
(1998)
The Many Faces of G Protein Signaling*
The Journal of Biological Chemistry, 273
-
N.
Jura,
Xuewu
Zhang,
Nicholas
Endres,
M.
Seeliger,
T.
Schindler,
J.
Kuriyan
(2011)
Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms.
Molecular cell, 42 1
-
H.
Ito,
N.
Klugbauer,
F.
Hofmann
(1997)
Transfer of the high affinity dihydropyridine sensitivity from L-type To non-L-type calcium channel.
Molecular pharmacology, 52 4
-
J.
Voegel,
M.
Heine,
M.
Tini,
V.
Vivat,
P.
Chambon,
H.
Gronemeyer
(1998)
The coactivator TIF2 contains three nuclear receptor‐binding motifs and mediates transactivation through CBP binding‐dependent and ‐independent pathways
The EMBO Journal, 17
-
C.
Rogers,
R.
Twyman,
R.
MacDonald
(1994)
Benzodiazepine and beta‐carboline regulation of single GABAA receptor channels of mouse spinal neurones in culture.
The Journal of Physiology, 475
-
D.
Ferry,
H.
Glossmann
(1982)
Evidence for multiple receptor sites within the putative calcium channel
Naunyn-Schmiedeberg's Archives of Pharmacology, 321
-
D.
Chiara,
Jonathan
Gill,
Qiang
Chen,
T.
Tillman,
W.
Dailey,
R.
Eckenhoff,
Yan
Xu,
P.
Tang,
Jonathan
Cohen
(2014)
Photoaffinity labeling the propofol binding site in GLIC.
Biochemistry, 53 1
-
H.
Nury,
C.
Renterghem,
Yun
Weng,
Alphonso
Tran,
M.
Baaden,
Virginie
Dufresne,
J.
Changeux,
J.
Sonner,
M.
Delarue,
P.
Corringer
(2011)
X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel
Nature, 469
-
F.
Ehlert
(1985)
The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium.
Molecular pharmacology, 28 5
-
Ayman
Hamouda,
T.
Kimm,
Jonathan
Cohen
(2013)
Physostigmine and Galanthamine Bind in the Presence of Agonist at the Canonical and Noncanonical Subunit Interfaces of a Nicotinic Acetylcholine Receptor
The Journal of Neuroscience, 33
-
Wei
Liu,
E.
Chun,
A.
Thompson,
P.
Chubukov,
Fei
Xu,
V.
Katritch,
G.
Han,
Christopher
Roth,
L.
Heitman,
A.
IJzerman,
V.
Cherezov,
R.
Stevens
(2012)
Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions
Science, 337
-
P.
Corringer,
F.
Poitevin,
M.
Prevost,
L.
Sauguet,
M.
Delarue,
J.
Changeux
(2012)
Structure and pharmacology of pentameric receptor channels: from bacteria to brain.
Structure, 20 6
-
J.
Changeux
(2010)
Allosteric receptors: from electric organ to cognition.
Annual review of pharmacology and toxicology, 50
-
J.
Gill,
Mari
Savolainen,
G.
Young,
R.
Zwart,
E.
Sher,
N.
Millar
(2008)
Agonist activation of α7 nicotinic acetylcholine receptors via an allosteric transmembrane site
Proceedings of the National Academy of Sciences, 108
-
D.
Bautista,
J.
Siemens,
Joshua
Glazer,
Pamela
Tsuruda,
A.
Basbaum,
C.
Stucky,
S.
Jordt,
D.
Julius
(2007)
The menthol receptor TRPM8 is the principal detector of environmental cold
Nature, 448
-
J.
Striessnig
(1999)
Pharmacology, Structure and Function of Cardiac L-Type Ca2+ Channels
Cellular Physiology and Biochemistry, 9
-
N.
Bocquet,
H.
Nury,
M.
Baaden,
C.
Poupon,
J.
Changeux,
M.
Delarue,
P.
Corringer
(2009)
X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation
Nature, 457
-
(2005)
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors
-
B.
Melancon,
C.
Hopkins,
M.
Wood,
K.
Emmitte,
C.
Niswender,
A.
Christopoulos,
P.
Conn,
C.
Lindsley
(2012)
Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery.
Journal of medicinal chemistry, 55 4
-
D.
Wootten,
A.
Christopoulos,
P.
Sexton
(2013)
Emerging paradigms in GPCR allostery: implications for drug discovery
Nature Reviews Drug Discovery, 12
-
R.
Hogg,
B.
Buisson,
D.
Bertrand
(2005)
Allosteric modulation of ligand-gated ion channels.
Biochemical pharmacology, 70 9
-
K.
Leach,
R.
Loiacono,
C.
Felder,
D.
McKinzie,
A.
Mogg,
David
Shaw,
P.
Sexton,
A.
Christopoulos
(2010)
Molecular Mechanisms of Action and In Vivo Validation of an M4 Muscarinic Acetylcholine Receptor Allosteric Modulator with Potential Antipsychotic Properties
Neuropsychopharmacology, 35
-
G.
Fenalti,
P.
Giguère,
V.
Katritch,
Xi-Ping
Huang,
A.
Thompson,
V.
Cherezov,
B.
Roth,
R.
Stevens
(2014)
Molecular control of δ-opioid receptor signalling
Nature, 506
-
Igor
Orlov,
N.
Rochel,
D.
Moras,
B.
Klaholz
(2012)
Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA
The EMBO Journal, 31
-
A.
Karlin
(1967)
On the application of "a plausible model" of allosteric proteins to the receptor for acetylcholine.
Journal of theoretical biology, 16 2
-
P.
Hess,
J.
Lansman,
R.
Tsien
(1984)
Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists
Nature, 311
-
B.
Olivera,
G.
Miljanich,
J.
Ramachandran,
M.
Adams
(1994)
CALCIUM CHANNEL DIVERSITY AND NEUROTRANSMITTER RELEASE : THE OMEGA -CONOTOXINS AND OMEGA -AGATOXINS
Annual Review of Biochemistry, 63
-
G.
Hockerman,
Barry
Johnson,
Michael
Abbott,
T.
Scheuer,
W.
Catterall
(1997)
Molecular Determinants of High Affinity Phenylalkylamine Block of l-type Calcium Channels in Transmembrane Segment IIIS6 and the Pore Region of the α1Subunit*
The Journal of Biological Chemistry, 272
-
F.
Revah,
D.
Bertrand,
J.
Galzi,
A.
Devillers-thiery,
C.
Mulle,
N.
Hussy,
S.
Bertrand,
M.
Ballivet,
J.
Changeux
(1991)
Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor
Nature, 353
-
J.
Lane,
P.
Sexton,
A.
Christopoulos
(2013)
Bridging the gap: bitopic ligands of G-protein-coupled receptors.
Trends in pharmacological sciences, 34 1
-
W.
Catterall
(1980)
Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes.
Annual review of pharmacology and toxicology, 20
-
Y.
Tao
(2008)
Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.
Pharmacology & therapeutics, 120 2
-
G.
Sawyer,
D.
Chiara,
R.
Olsen,
Jonathan
Cohen
(2002)
Identification of the Bovine γ-Aminobutyric Acid Type A Receptor α Subunit Residues Photolabeled by the Imidazobenzodiazepine [3H]Ro15-4513*
The Journal of Biological Chemistry, 277
-
T.
Frey
(2014)
Faculty Opinions recommendation of TRPV1 structures in distinct conformations reveal activation mechanisms.
-
A.
Taly,
P.
Corringer,
T.
Grutter,
L.
Carvalho,
M.
Karplus,
J.
Changeux
(2006)
Implications of the quaternary twist allosteric model for the physiology and pathology of nicotinic acetylcholine receptors
Proceedings of the National Academy of Sciences, 103
-
Jianzhong
Chen,
D.
Hage
(2004)
Quantitative analysis of allosteric drug-protein binding by biointeraction chromatography
Nature Biotechnology, 22
-
A.
Arkhipov,
Yibing
Shan,
Rahul
Das,
Nicholas
Endres,
M.
Eastwood,
D.
Wemmer,
J.
Kuriyan,
D.
Shaw
(2013)
Architecture and Membrane Interactions of the EGF Receptor
Cell, 152
-
C.
Hunter,
H.
Anderson
(2009)
What is cooperativity?
Angewandte Chemie, 48 41
-
D.
Wootten,
J.
Simms,
Cassandra
Koole,
O.
Woodman,
R.
Summers,
A.
Christopoulos,
P.
Sexton
(2011)
Modulation of the Glucagon-Like Peptide-1 Receptor Signaling by Naturally Occurring and Synthetic Flavonoids
Journal of Pharmacology and Experimental Therapeutics, 336
-
M.
Dong,
R.
Cox,
L.
Miller
(2009)
Juxtamembranous Region of the Amino Terminus of the Family B G Protein-coupled Calcitonin Receptor Plays a Critical Role in Small-molecule Agonist Action*
The Journal of Biological Chemistry, 284
-
Guodong
Li,
D.
Chiara,
G.
Sawyer,
S.
Husain,
R.
Olsen,
Jonathan
Cohen
(2006)
Identification of a GABAA Receptor Anesthetic Binding Site at Subunit Interfaces by Photolabeling with an Etomidate Analog
The Journal of Neuroscience, 26
-
S.
Sokolov,
R.
Kraus,
T.
Scheuer,
W.
Catterall
(2008)
Inhibition of Sodium Channel Gating by Trapping the Domain II Voltage Sensor with Protoxin II
Molecular Pharmacology, 73
-
G.
Flynn,
K.
Black,
L.
Islas,
B.
Sankaran,
W.
Zagotta
(2007)
Structure and rearrangements in the carboxy-terminal region of SpIH channels.
Structure, 15 6
-
J.
Hardy,
J.
Wells
(2004)
Searching for new allosteric sites in enzymes.
Current opinion in structural biology, 14 6
-
M.
Sinnegger,
Zheng
Wang,
M.
Grabner,
S.
Hering,
J.
Striessnig,
H.
Glossmann,
J.
Mitterdorfer
(1997)
Nine L-type Amino Acid Residues Confer Full 1,4-Dihydropyridine Sensitivity to the Neuronal Calcium Channel α1ASubunit
The Journal of Biological Chemistry, 272
-
K.
Hansen,
Kevin
Ogden,
S.
Traynelis
(2012)
Subunit-Selective Allosteric Inhibition of Glycine Binding to NMDA Receptors
The Journal of Neuroscience, 32
-
P.
Yuan,
M.
Leonetti,
Alexander
Pico,
Yichun
Hsiung,
R.
MacKinnon
(2010)
Structure of the Human BK Channel Ca2+-Activation Apparatus at 3.0 Å Resolution
Science, 329
-
M.
Spedding,
B.
Kenny,
P.
Chatelain
(1995)
New drug binding sites in Ca2+ channels.
Trends in pharmacological sciences, 16 4
-
J.
Norris,
L.
Paige,
D.
Christensen,
Ching-Yi
Chang,
Maria
Huacani,
Daju
Fan,
Paul
Hamilton,
D.
Fowlkes,
D.
McDonnell
(1999)
Peptide antagonists of the human estrogen receptor.
Science, 285 5428
-
N.
Popovych,
S.
Tzeng,
M.
Tonelli,
R.
Ebright,
C.
Kalodimos
(2009)
Structural basis for cAMP-mediated allosteric control of the catabolite activator protein
Proceedings of the National Academy of Sciences, 106
-
E.
Estébanez-Perpiñá,
L.
Arnold,
P.
Nguyen,
E.
Rodrigues,
Ellena
Mar,
R.
Bateman,
P.
Pallai,
K.
Shokat,
J.
Baxter,
R.
Guy,
P.
Webb,
R.
Fletterick
(2007)
A surface on the androgen receptor that allosterically regulates coactivator binding
Proceedings of the National Academy of Sciences, 104
-
L.
Arnold,
Aaron
Kosinski,
E.
Estébanez-Perpiñá,
R.
Fletterick,
R.
Guy
(2007)
Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.
Journal of medicinal chemistry, 50 22
-
T.
Kenakin
(2005)
New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism
Nature Reviews Drug Discovery, 4
-
F.
Ehlert
(1988)
Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.
Molecular pharmacology, 33 2
-
E.
Estébanez-Perpiñá,
L.
Arnold,
N.
Jouravel,
Marie
Togashi,
J.
Blethrow,
Ellena
Mar,
P.
Nguyen,
K.
Phillips,
J.
Baxter,
P.
Webb,
R.
Guy,
R.
Fletterick
(2007)
Structural insight into the mode of action of a direct inhibitor of coregulator binding to the thyroid hormone receptor.
Molecular endocrinology, 21 12
-
C.
Grimm,
Eduardo
Aneiros,
M.
Groot
(2011)
Dissecting TRPV1: Lessons to be learned?
Channels, 5
-
J.
Winterfield,
Kenton
Swartz
(2000)
A Hot Spot for the Interaction of Gating Modifier Toxins with Voltage-Dependent Ion Channels
The Journal of General Physiology, 116
-
K.
Jacobson,
Zhang-Guo
Gao
(2006)
Adenosine receptors as therapeutic targets
Nature Reviews Drug Discovery, 5
-
S.
Srinivasan,
J.
Nwachukwu,
A.
Parent,
Valerie
Cavett,
J.
Nowak,
T.
Hughes,
D.
Kojetin,
J.
Katzenellenbogen,
K.
Nettles
(2013)
Ligand-binding dynamics rewire cellular signaling via Estrogen Receptor-α
Nature chemical biology, 9
-
W.
Catterall,
A.
Goldin,
S.
Waxman
(2005)
International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels
Pharmacological Reviews, 57
-
Andre
Lean,
J.
Stadel,
Robert
Lefkowitzl
(1980)
A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor.
The Journal of biological chemistry, 255 15
-
Martin
Price,
G.
Baillie,
A.
Thomas,
L.
Stevenson,
M.
Easson,
R.
Goodwin,
Adèle
McLean,
L.
McIntosh,
G.
Goodwin,
G.
Walker,
P.
Westwood,
Julia
Marrs,
F.
Thomson,
P.
Cowley,
A.
Christopoulos,
R.
Pertwee,
R.
Ross
(2005)
Allosteric Modulation of the Cannabinoid CB1 Receptor
Molecular Pharmacology, 68
-
B.
Nolen,
Susan
Taylor,
G.
Ghosh
(2004)
Regulation of protein kinases; controlling activity through activation segment conformation.
Molecular cell, 15 5
-
N.
Nguyen,
J.
Apriletti,
Suzana
Lima,
P.
Webb,
J.
Baxter,
T.
Scanlan
(2002)
Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment.
Journal of medicinal chemistry, 45 15
-
S.
Jones
(1999)
Commentary: a plausible model.
The Journal of general physiology, 114 2
-
K.
Hansen,
S.
Traynelis
(2011)
Structural and Mechanistic Determinants of a Novel Site for Noncompetitive Inhibition of GluN2D-Containing NMDA Receptors
The Journal of Neuroscience, 31
-
J.
Albanell,
J.
Codony,
A.
Rovira,
B.
Mellado,
P.
Gascón
(2003)
Mechanism of action of anti-HER2 monoclonal antibodies: scientific update on trastuzumab and 2C4.
Advances in experimental medicine and biology, 532
-
J.
Bruning,
A.
Parent,
G.
Gil,
Min
Zhao,
J.
Nowak,
Margaret
Pace,
Carolyn
Smith,
P.
Afonine,
P.
Adams,
J.
Katzenellenbogen,
K.
Nettles
(2010)
Coupling of Receptor Conformation and Ligand Orientation Determine Graded Activity
Nature chemical biology, 6
-
S.
Lazareno,
A.
Popham,
N.
Birdsall
(2002)
Analogs of WIN 62,577 define a second allosteric site on muscarinic receptors.
Molecular pharmacology, 62 6
-
M.
Lewis,
G.
Chang,
N.
Horton,
M.
Kercher,
H.
Pace,
M.
Schumacher,
R.
Brennan,
P.
Lu
(1996)
Crystal Structure of the Lactose Operon Repressor and Its Complexes with DNA and Inducer
Science, 271
-
J.
Gerhart,
A.
Pardee
(1962)
The enzymology of control by feedback inhibition.
The Journal of biological chemistry, 237
-
T.
Burris,
L.
Solt,
Yongjun
Wang,
Christine
Crumbley,
Subhashish
Banerjee,
K.
Griffett,
T.
Lundåsen,
T.
Hughes,
D.
Kojetin
(2013)
Nuclear Receptors and Their Selective Pharmacologic Modulators
Pharmacological Reviews, 65
-
D.
Morgan
(1996)
The dynamics of cyclin dependent kinase structure.
Current opinion in cell biology, 8 6
-
K.
Niefind,
J.
Raaf,
O.
Issinger
(2009)
Protein kinase CK2: from structures to insights
Cellular and Molecular Life Sciences, 66
-
R.
Janis,
J.
Sarmiento,
S.
Maurer,
G.
Bolger,
D.
Triggle
(1984)
Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
The Journal of pharmacology and experimental therapeutics, 231 1
-
L.
Knudsen,
D.
Kiel,
M.
Teng,
C.
Behrens,
D.
Bhumralkar,
J.
Kodra,
J.
Holst,
C.
Jeppesen,
Michael
Johnson,
J.
Jong,
A.
Jørgensen,
T.
Kercher,
Jarek
Kostrowicki,
P.
Madsen,
P.
Olesen,
J.
Petersen,
F.
Poulsen,
U.
Sidelmann,
J.
Sturis,
L.
Truesdale,
J.
May,
J.
Lau
(2007)
Small-molecule agonists for the glucagon-like peptide 1 receptor
Proceedings of the National Academy of Sciences, 104
-
J.
Black
(1989)
Drugs from Emasculated Hormones: The Principle of Syntopic Antagonism
Bioscience Reports, 24
-
D.
Moras,
H.
Gronemeyer
(1998)
The nuclear receptor ligand-binding domain: structure and function.
Current opinion in cell biology, 10 3
-
Grace
Poon
(2005)
Cinacalcet Hydrochloride (Sensipar)
Baylor University Medical Center Proceedings, 18
-
Stephane
Litschig,
F.
Gasparini,
Doris
Rueegg,
N.
Stoehr,
P.
Flor,
I.
Vranesic,
L.
Prézeau,
J.
Pin,
C.
Thomsen,
R.
Kuhn
(1999)
CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding.
Molecular pharmacology, 55 3
-
I.
Kufareva,
R.
Abagyan
(2008)
Type-II kinase inhibitor docking, screening, and profiling using modified structures of active kinase states.
Journal of medicinal chemistry, 51 24
-
R.
Neubig,
M.
Spedding,
T.
Kenakin,
A.
Christopoulos
(2003)
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology
Pharmacological Reviews, 55
-
P.
Dorr,
M.
Westby,
Susan
Dobbs,
P.
Griffin,
B.
Irvine,
M.
Macartney,
J.
Mori,
G.
Rickett,
C.
Smith-Burchnell,
C.
Napier,
R.
Webster,
D.
Armour,
David
Price,
B.
Stammen,
A.
Wood,
M.
Perros
(2005)
Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity
Antimicrobial Agents and Chemotherapy, 49
-
A.
Fenton
(2008)
Allostery: an illustrated definition for the 'second secret of life'.
Trends in biochemical sciences, 33 9
-
A.
Conigrave,
S.
Quinn,
E.
Brown
(2000)
L-amino acid sensing by the extracellular Ca2+-sensing receptor.
Proceedings of the National Academy of Sciences of the United States of America, 97 9
-
J.
Black,
V.
Gerskowitch,
P.
Left,
N.
Shankley
(1986)
Analysis of competitive antagonism when this property occurs as part of a pharmacological resultant
British Journal of Pharmacology, 89
-
J.
Torchia,
D.
Rose,
J.
Inostroza,
Yasutomi
Kamei,
S.
Westin,
C.
Glass,
M.
Rosenfeld
(1997)
The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
Nature, 387
-
Haijuan
Yang,
Derek
Rudge,
J.
Koos,
B.
Vaidialingam,
Hyo
Yang,
N.
Pavletich
(2013)
mTOR kinase structure, mechanism and regulation by the rapamycin-binding domain
Nature, 497
-
P.
Kruijf,
H.
Lim,
L.
Roumen,
V.
Renjaän,
Jiuqiao
Zhao,
M.
Webb,
D.
Auld,
J.
Wijkmans,
G.
Zaman,
M.
Smit,
C.
Graaf,
R.
Leurs
(2011)
Identification of a Novel Allosteric Binding Site in the CXCR2 Chemokine Receptor
Molecular Pharmacology, 80
-
M.
Cazorla,
A.
Jouvenceau,
Christiane
Rose,
J.
Guilloux,
C.
Pilon,
A.
Dranovsky,
J.
Prémont
(2010)
Cyclotraxin-B, the First Highly Potent and Selective TrkB Inhibitor, Has Anxiolytic Properties in Mice
PLoS ONE, 5
-
N.
Mettu,
T.
Stanley,
M.
Dwyer,
M.
Jansen,
John
Allen,
J.
Hall,
D.
McDonnell
(2007)
The nuclear receptor-coactivator interaction surface as a target for peptide antagonists of the peroxisome proliferator-activated receptors.
Molecular endocrinology, 21 10
-
Xuerong
Wang,
Shi-Yong
Sun
(2009)
Enhancing mTOR-targeted cancer therapy
Expert Opinion on Therapeutic Targets, 13
-
M.
Rubin,
J.
Changeux
(1966)
On the nature of allosteric transitions: implications of non-exclusive ligand binding.
Journal of molecular biology, 21 2
-
K.
Hollenstein,
J.
Kean,
A.
Bortolato,
R.
Cheng,
A.
Doré,
A.
Jazayeri,
R.
Cooke,
M.
Weir,
F.
Marshall
(2013)
Structure of class B GPCR corticotropin-releasing factor receptor 1
Nature, 499
-
Timothy
Acker,
Hongjie
Yuan,
K.
Hansen,
Katie
Vance,
Kevin
Ogden,
H.
Jensen,
P.
Burger,
Praseeda
Mullasseril,
J.
Snyder,
D.
Liotta,
S.
Traynelis
(2011)
Mechanism for Noncompetitive Inhibition by Novel GluN2C/D N-Methyl-d-aspartate Receptor Subunit-Selective Modulators
Molecular Pharmacology, 80
-
S.
Cowan-Jacob
(2006)
Structural biology of protein tyrosine kinases
Cellular and Molecular Life Sciences CMLS, 63
-
M.
Noetzel,
K.
Gregory,
P.
Vinson,
J.
Manka,
S.
Stauffer,
C.
Lindsley,
C.
Niswender,
Zixiu
Xiang,
P.
Conn
(2013)
A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling
Molecular Pharmacology, 83
-
M.
Vieth,
J.
Sutherland,
D.
Robertson,
R.
Campbell
(2005)
Kinomics: characterizing the therapeutically validated kinase space.
Drug discovery today, 10 12
-
P.
Tauber
(1973)
Inhibition of lysosomal plasminogen activator activity in experimental shock.
Pharmacology, 9 1
-
A.
Lanzafame,
P.
Sexton,
A.
Christopoulos
(2006)
Interaction Studies of Multiple Binding Sites on M4 Muscarinic Acetylcholine Receptors
Molecular Pharmacology, 70
-
J.
Schlessinger
(2000)
Cell Signaling by Receptor Tyrosine Kinases
Cell, 103
-
N.
Hynes,
H.
Lane
(2005)
ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors
Nature Reviews Cancer, 5
-
J.
Ohren,
Huifen
Chen,
A.
Pavlovsky,
C.
Whitehead,
E.
Zhang,
Peter
Kuffa,
Chunhong
Yan,
P.
McConnell,
Cindy
Spessard,
C.
Banotai,
W.
Mueller,
Amy
Delaney,
C.
Omer,
J.
Sebolt-Leopold,
D.
Dudley,
I.
Leung,
C.
Flamme,
J.
Warmus,
Michael
Kaufman,
S.
Barrett,
H.
Tecle,
C.
Hasemann
(2004)
Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition
Nature Structural &Molecular Biology, 11
-
C.
Valant,
C.
Felder,
P.
Sexton,
A.
Christopoulos
(2012)
Probe Dependence in the Allosteric Modulation of a G Protein-Coupled Receptor: Implications for Detection and Validation of Allosteric Ligand Effects
Molecular Pharmacology, 81
-
Susan
Taylor,
A.
Kornev
(2011)
Protein kinases: evolution of dynamic regulatory proteins.
Trends in biochemical sciences, 36 2
-
S.
Long,
X.
Tao,
E.
Campbell,
R.
MacKinnon
(2007)
Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment
Nature, 450
-
C.
Valant,
J.
Lane,
P.
Sexton,
A.
Christopoulos
(2012)
The best of both worlds? Bitopic orthosteric/allosteric ligands of g protein-coupled receptors.
Annual review of pharmacology and toxicology, 52
-
A.
IJzerman,
I.
Wijngaarden,
W.
Soudijn
(2001)
Allosteric modulation of G-protein-coupled receptors
Expert Opinion on Therapeutic Patents, 11
-
D.
Heery,
E.
Kalkhoven,
S.
Hoare,
M.
Parker
(1997)
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Nature, 387
-
J.
Changeux,
S.
Edelstein
(1998)
Allosteric receptors after 30 years
Rendiconti Lincei, 17
-
Vindhya
Nawaratne,
K.
Leach,
C.
Felder,
P.
Sexton,
A.
Christopoulos
(2010)
Structural Determinants of Allosteric Agonism and Modulation at the M4 Muscarinic Acetylcholine Receptor
The Journal of Biological Chemistry, 285
-
Ching-Yi
Chang,
J.
Norris,
H.
Grøn,
L.
Paige,
P.
Hamilton,
D.
Kenan,
D.
Fowlkes,
D.
McDonnell
(1999)
Dissection of the LXXLL Nuclear Receptor-Coactivator Interaction Motif Using Combinatorial Peptide Libraries: Discovery of Peptide Antagonists of Estrogen Receptors α and β
Molecular and Cellular Biology, 19
-
B.
Nilius,
K.
Talavera,
G.
Owsianik,
J.
Prenen,
G.
Droogmans,
T.
Voets
(2005)
Gating of TRP channels: a voltage connection?
The Journal of Physiology, 567
-
Corrie
dacosta,
Sarah
Medaglia,
N.
Lavigne,
Shuzhi
Wang,
Casey
Carswell,
J.
Baenziger
(2009)
Anionic Lipids Allosterically Modulate Multiple Nicotinic Acetylcholine Receptor Conformational Equilibria*
The Journal of Biological Chemistry, 284
-
A.
Gilman
(1987)
G proteins: transducers of receptor-generated signals.
Annual review of biochemistry, 56
-
Thron
Cd
(1973)
On the analysis of pharmacological experiments in terms of an allosteric receptor model.
Molecular Pharmacology, 9
-
P.
Cuatrecasas
(1974)
Membrane receptors.
Annual review of biochemistry, 43 0
-
Yong
Wang,
N.
Chirgadze,
S.
Briggs,
Sohaib
Khan,
E.
Jensen,
T.
Burris
(2006)
A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta.
Proceedings of the National Academy of Sciences of the United States of America, 103 26
-
U.
Benjamin,
K.
and,
Reinhard
Seifert
(2002)
Cyclic nucleotide-gated ion channels.
Physiological reviews, 82 3
-
Ernesto
Vargas,
V.
Yarov-Yarovoy,
Fatemeh
Khalili-Araghi,
W.
Catterall,
M.
Klein,
M.
Tarek,
E.
Lindahl,
K.
Schulten,
E.
Perozo,
F.
Bezanilla,
B.
Roux
(2012)
An emerging consensus on voltage-dependent gating from computational modeling and molecular dynamics simulations
The Journal of General Physiology, 140
-
Yi
Liu,
N.
Gray
(2006)
Rational design of inhibitors that bind to inactive kinase conformations
Nature Chemical Biology, 2
-
D.
Ragsdale,
J.
McPhee,
T.
Scheuer,
W.
Catterall
(1994)
Molecular determinants of state-dependent block of Na+ channels by local anesthetics.
Science, 265 5179
-
C.
Langmead
(2011)
Determining allosteric modulator mechanism of action: integration of radioligand binding and functional assay data.
Methods in molecular biology, 746
-
M.
Allegretti,
R.
Bertini,
C.
Bizzarri,
A.
Beccari,
A.
Mantovani,
M.
Locati
(2008)
Allosteric inhibitors of chemoattractant receptors: opportunities and pitfalls.
Trends in pharmacological sciences, 29 6
-
David
Hall
(2000)
Modeling the functional effects of allosteric modulators at pharmacological receptors: an extension of the two-state model of receptor activation.
Molecular pharmacology, 58 6
-
E.
Kostenis,
K.
Mohr
(1996)
Two-point kinetic experiments to quantify allosteric effects on radioligand dissociation.
Trends in pharmacological sciences, 17 8
-
D.
Colquhoun,
R.
Lape
Perspectives on : Conformational coupling in ion channels Allosteric coupling in ligand-gated ion channels
-
E.
Bourinet,
T.
Soong,
K.
Sutton,
S.
Slaymaker,
E.
Mathews,
A.
Monteil,
G.
Zamponi,
J.
Nargeot,
T.
Snutch
(1999)
Splicing of α1A subunit gene generates phenotypic variants of P- and Q-type calcium channels
Nature Neuroscience, 2
-
Longjun
Wu,
Tara-Beth
Sweet,
D.
Clapham
(2010)
International Union of Basic and Clinical Pharmacology. LXXVI. Current Progress in the Mammalian TRP Ion Channel Family
Pharmacological Reviews, 62
-
D.
Nicholls,
N.
Tomkinson,
K.
Wiley,
A.
Brammall,
Lorna
Bowers,
C.
Grahames,
A.
Gaw,
P.
Meghani,
P.
Shelton,
T.
Wright,
P.
Mallinder
(2008)
Identification of a Putative Intracellular Allosteric Antagonist Binding-Site in the CXC Chemokine Receptors 1 and 2
Molecular Pharmacology, 74
-
R.
Olsen,
Chang-sheng
Chang,
Guodong
Li,
H.
Hanchar,
M.
Wallner
(2004)
Fishing for allosteric sites on GABA(A) receptors.
Biochemical pharmacology, 68 8
-
J.
Monod,
F.
Jacob
(1961)
Teleonomic mechanisms in cellular metabolism, growth, and differentiation.
Cold Spring Harbor symposia on quantitative biology, 26
-
Zhiyi
Yu,
Elisabeth
Klaasse,
L.
Heitman,
A.
IJzerman
(2014)
Allosteric modulators of the hERG K(+) channel: radioligand binding assays reveal allosteric characteristics of dofetilide analogs.
Toxicology and applied pharmacology, 274 1
-
F.
Bono,
F.
Smet,
C.
Herbert,
Katrien
Bock,
M.
Georgiadou,
P.
Fons,
M.
Tjwa,
C.
Alcouffe,
A.
Ny,
M.
Bianciotto,
B.
Jonckx,
M.
Murakami,
A.
Lanahan,
Christof
Michielsen,
D.
Sibrac,
F.
Dol-Gleizes,
M.
Mazzone,
S.
Zacchigna,
J.
Herault,
C.
Fischer,
P.
Rigon,
Carmen
Almodóvar,
Filip
Claes,
I.
Blanc,
K.
Poesen,
Jie
Zhang,
I.
Segura,
G.
Gueguen,
M.
Bordes,
D.
Lambrechts,
Roselyne
Broussy,
M.
Wouwer,
C.
Michaux,
T.
Shimada,
Isabelle
Jean,
S.
Blacher,
A.
Noel,
P.
Motte,
E.
Rom,
J.
Rakic,
S.
Katsuma,
P.
Schaeffer,
A.
Yayon,
A.
Schepdael,
H.
Schwalbe,
F.
Gervasio,
G.
Carmeliet,
Jef
Rozensky,
M.
Dewerchin,
M.
Simons,
A.
Christopoulos,
J.
Herbert,
P.
Carmeliet
(2013)
Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties.
Cancer cell, 23 4
-
K.
Mohr,
Jens
Schmitz,
R.
Schrage,
C.
Tränkle,
U.
Holzgrabe
(2013)
Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
Angewandte Chemie, 52 2
-
(2011)
A (2011) Allostery in GPCRs: ‘MWC
-
Jianming
Zhang,
F.
Adrián,
W.
Jahnke,
S.
Cowan-Jacob,
Allen
Li,
Roxana
Iacob,
Taebo
Sim,
John
Powers,
C.
Dierks,
Fangxian
Sun,
G.
Guo,
Q.
Ding,
Barun
Okram,
Yongmun
Choi,
Amy
Wojciechowski,
Xianming
Deng,
Guoxun
Liu,
G.
Fendrich,
A.
Strauss,
N.
Vajpai,
S.
Grzesiek,
T.
Tuntland,
Yi
Liu,
B.
Bursulaya,
M.
Azam,
P.
Manley,
J.
Engen,
G.
Daley,
M.
Warmuth,
N.
Gray
(2010)
Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
Nature, 463
-
J.
Pin,
R.
Neubig,
M.
Bouvier,
L.
Devi,
M.
Filizola,
J.
Javitch,
M.
Lohse,
G.
Milligan,
K.
Palczewski,
M.
Parmentier,
M.
Spedding
(2007)
International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers
Pharmacological Reviews, 59
-
A.
Leduc,
J.
Trent,
J.
Wittliff,
K.
Bramlett,
S.
Briggs,
N.
Chirgadze,
Yong
Wang,
T.
Burris,
A.
Spatola
(2003)
Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor–coactivator interactions
Proceedings of the National Academy of Sciences of the United States of America, 100
-
Q.
Cui,
M.
Karplus
(2008)
Allostery and cooperativity revisited
Protein Science, 17
-
S.
Rasmussen,
Brian
DeVree,
Y.
Zou,
A.
Kruse,
K.
Chung,
T.
Kobilka,
Foon
Thian,
P.
Chae,
E.
Pardon,
D.
Calinski,
J.
Mathiesen,
S.
Shah,
J.
Lyons,
M.
Caffrey,
S.
Gellman,
J.
Steyaert,
G.
Skiniotis,
W.
Weis,
R.
Sunahara,
B.
Kobilka
(2011)
Crystal Structure of the β2Adrenergic Receptor-Gs protein complex
Nature, 477
-
W.
Catterall,
E.
Perez-Reyes,
T.
Snutch,
J.
Striessnig
(2005)
International Union of Pharmacology. XLVIII. Nomenclature and Structure-Function Relationships of Voltage-Gated Calcium Channels
Pharmacological Reviews, 57
-
A.
Venkatakrishnan,
X.
Deupí,
G.
Lebon,
C.
Tate,
G.
Schertler,
G.
Schertler,
M.
Babu
(2013)
Molecular signatures of G-protein-coupled receptors
Nature, 494
-
T.
Hughes,
P.
Giri,
Ian
Vera,
D.
Marciano,
Dana
Kuruvilla,
Y.
Shin,
A.
Blayo,
T.
Kamenecka,
T.
Burris,
P.
Griffin,
D.
Kojetin
(2014)
An alternate binding site for PPARγ ligands
Nature communications, 5
-
E.
Wood,
A.
Truesdale,
O.
McDonald,
D.
Yuan,
A.
Hassell,
S.
Dickerson,
B.
Ellis,
C.
Pennisi,
E.
Horne,
K.
Lackey,
K.
Alligood,
D.
Rusnak,
T.
Gilmer,
L.
Shewchuk
(2004)
A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)
Cancer Research, 64
-
A.
Christopoulos
(2002)
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery
Nature Reviews Drug Discovery, 1
-
J.
Monod,
J.
Changeux,
F.
Jacob
(1963)
Allosteric proteins and cellular control systems.
Journal of molecular biology, 6
-
J.
Galzi,
J.
Changeux
(1994)
Neurotransmitter-gated ion channels as unconventional allosteric proteins
Current Opinion in Structural Biology, 4
-
Jean-Luc
Galzil,
S.
Bertrand,
P.
Corringer,
J.
Changeux,
Daniel
Bertrand
(1996)
Identification of calcium binding sites that regulate potentiation of a neuronal nicotinic acetylcholine receptor.
The EMBO Journal, 15
-
M.
Nowycky,
A.
Fox,
R.
Tsien
(1985)
Three types of neuronal calcium channel with different calcium agonist sensitivity
Nature, 316
-
S.
Cestèle,
W.
Catterall
(2000)
Molecular mechanisms of neurotoxin action on voltage-gated sodium channels.
Biochimie, 82 9-10
-
D.
Fabbro,
P.
Manley,
W.
Jahnke,
J.
Liebetanz,
Alexandra
Szyttenholm,
G.
Fendrich,
A.
Strauss,
Jianming
Zhang,
N.
Gray,
F.
Adrián,
M.
Warmuth,
X.
Pelle,
R.
Grotzfeld,
F.
Berst,
A.
Marzinzik,
S.
Cowan-Jacob,
P.
Furet,
J.
Mestan
(2010)
Inhibitors of the Abl kinase directed at either the ATP- or myristate-binding site.
Biochimica et biophysica acta, 1804 3
-
J.
Changeux
(1961)
The feedback control mechanisms of biosynthetic L-threonine deaminase by L-isoleucine.
Cold Spring Harbor symposia on quantitative biology, 26
-
D.
Colquhoun
(2007)
Why the Schild method is better than Schild realised.
Trends in pharmacological sciences, 28 12
-
F.
Ehlert
(2005)
Analysis of Allosterism in Functional Assays
Journal of Pharmacology and Experimental Therapeutics, 315
-
M.
Vieth,
R.
Higgs,
D.
Robertson,
M.
Shapiro,
Ellen
Gragg,
H.
Hemmerle
(2004)
Kinomics-structural biology and chemogenomics of kinase inhibitors and targets.
Biochimica et biophysica acta, 1697 1-2
-
A.
LaFrate,
J.
Gunther,
K.
Carlson,
J.
Katzenellenbogen
(2008)
Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor.
Bioorganic & medicinal chemistry, 16 23
-
Jianming
Zhang,
Priscilla
Yang,
N.
Gray
(2009)
Targeting cancer with small molecule kinase inhibitors
Nature Reviews Cancer, 9
-
D.
Chiara,
S.
Jayakar,
Xiaojuan
Zhou,
Xi
Zhang,
P.
Savechenkov,
K.
Bruzik,
K.
Miller,
Jonathan
Cohen
(2013)
Specificity of Intersubunit General Anesthetic-binding Sites in the Transmembrane Domain of the Human α1β3γ2 γ-Aminobutyric Acid Type A (GABAA) Receptor*♦
The Journal of Biological Chemistry, 288
-
K.
Leach,
Adriel
Wen,
A.
Cook,
P.
Sexton,
A.
Conigrave,
A.
Christopoulos
(2013)
Impact of clinically relevant mutations on the pharmacoregulation and signaling bias of the calcium-sensing receptor by positive and negative allosteric modulators.
Endocrinology, 154 3
-
J.
Changeux,
S.
Edelstein
(2005)
Allosteric Mechanisms of Signal Transduction
Science, 308
-
J.
Proska,
S.
Tuček
(1994)
Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.
Molecular pharmacology, 45 4
-
D.
Colquhoun
(1998)
Binding, gating, affinity and efficacy: The interpretation of structure‐activity relationships for agonists and of the effects of mutating receptors
British Journal of Pharmacology, 125
-
I.
Zimmermann,
A.
Marabelli,
C.
Bertozzi,
L.
Sivilotti,
R.
Dutzler
(2012)
Inhibition of the Prokaryotic Pentameric Ligand-Gated Ion Channel ELIC by Divalent Cations
PLoS Biology, 10
-
Geoffrey
Smith,
R.
Olsen
(2000)
Deduction of amino acid residues in the GABAA receptor α subunits photoaffinity labeled with the benzodiazepine flunitrazepam
Neuropharmacology, 39
-
R.
Krause,
B.
Buisson,
S.
Bertrand,
P.
Corringer,
J.
Galzi,
J.
Changeux,
D.
Bertrand
(1998)
Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor.
Molecular pharmacology, 53 2
-
R.
Olsen,
Guodong
Li,
M.
Wallner,
J.
Trudell,
E.
Bertaccini,
E.
Lindahl,
K.
Miller,
R.
Alkana,
D.
Davies
(2014)
Structural models of ligand-gated ion channels: sites of action for anesthetics and ethanol.
Alcoholism, clinical and experimental research, 38 3
-
C.
Herbert,
Ulrich
Schieborr,
K.
Saxena,
J.
Juraszek,
F.
Smet,
C.
Alcouffe,
M.
Bianciotto,
G.
Saladino,
D.
Sibrac,
D.
Kudlinzki,
S.
Sreeramulu,
Alan
Brown,
P.
Rigon,
J.
Herault,
G.
Lassalle,
T.
Blundell,
F.
Rousseau,
A.
Gils,
J.
Schymkowitz,
P.
Tompa,
J.
Herbert,
P.
Carmeliet,
F.
Gervasio,
H.
Schwalbe,
F.
Bono
(2013)
Molecular mechanism of SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signaling.
Cancer cell, 23 4
-
K.
Landgraf,
L.
Santell,
K.
Billeci,
C.
Quan,
Judy
Young,
H.
Maun,
D.
Kirchhofer,
R.
Lazarus
(2010)
Allosteric Peptide Activators of Pro-Hepatocyte Growth Factor Stimulate Met Signaling
The Journal of Biological Chemistry, 285
-
R.
Keynes
(1975)
The ionic channels in excitable membranes.
Ciba Foundation symposium, 31
-
L.
Sauguet,
A.
Shahsavar,
F.
Poitevin,
C.
Huon,
A.
Menny,
Á.
Nemecz,
A.
Haouz,
J.
Changeux,
P.
Corringer,
M.
Delarue
(2013)
Crystal structures of a pentameric ligand-gated ion channel provide a mechanism for activation
Proceedings of the National Academy of Sciences, 111
-
Nomenclature for Ligand-Receptor Allostery
-
J.
Changeux
(2013)
The concept of allosteric modulation: an overview.
Drug discovery today. Technologies, 10 2
-
C.
Chang,
J.
Norris,
H.
Grøn,
L.
Paige,
P.
Hamilton,
D.
Kenan,
D.
Fowlkes,
D.
McDonnell
(1999)
Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta.
Molecular and cellular biology, 19 12
-
N.
Novère,
T.
Grutter,
J.
Changeux
(2002)
Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites
Proceedings of the National Academy of Sciences of the United States of America, 99
-
M.
Spedding
(1985)
Activators and inactivators of Ca++ channels: new perspectives.
Journal de pharmacologie, 16 4
-
J.
Schnitzer,
P.
Oh,
D.
Mcintosh
(1996)
Role of GTP Hydrolysis in Fission of Caveolae Directly from Plasma Membranes
Science, 274
-
V.
Cockcroft,
D.
Osguthorpe,
E.
Barnard,
A.
Friday,
G.
Lunt
(2007)
Ligand-gated ion channels
Molecular Neurobiology, 4
-
B.
Katz,
S.
Thesleff
(1957)
A study of the ‘desensitization’ produced by acetylcholine at the motor end‐plate
The Journal of Physiology, 138
-
R.
Hibbs,
E.
Gouaux
(2011)
Principles of activation and permeation in an anion-selective Cys-loop receptor
Nature, 474
-
J.
Pin,
L.
Prézeau
(2007)
Allosteric Modulators of GABAB Receptors: Mechanism of Action and Therapeutic Perspective
Current Neuropharmacology, 5
-
J.
Monod,
J.
Wyman,
J.
Changeux
(1965)
ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.
Journal of molecular biology, 12
-
W.
Catterall
(2010)
Ion Channel Voltage Sensors: Structure, Function, and Pathophysiology
Neuron, 67
-
T.
Costa,
A.
Herz
(1989)
Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins.
Proceedings of the National Academy of Sciences of the United States of America, 86 19
-
K.
Niefind,
J.
Raaf,
O.
Issinger
(2009)
Protein Kinase CK2 in Health and Disease
Cellular and Molecular Life Sciences, 66
-
A.
Pantazis,
R.
Olcese
(2012)
Relative transmembrane segment rearrangements during BK channel activation resolved by structurally assigned fluorophore–quencher pairing
The Journal of General Physiology, 140
-
Á.
Nemecz,
P.
Taylor
(2011)
Creating an α7 Nicotinic Acetylcholine Recognition Domain from the Acetylcholine-binding Protein
The Journal of Biological Chemistry, 286
-
D.
Kern,
E.
Zuiderweg
(2003)
The role of dynamics in allosteric regulation.
Current opinion in structural biology, 13 6
-
P.
Conn,
A.
Christopoulos,
C.
Lindsley,
C.
Lindsley
(2009)
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Nature Reviews Drug Discovery, 8
-
F.
Zuccotto,
E.
Ardini,
E.
Casale,
M.
Angiolini
(2010)
Through the "gatekeeper door": exploiting the active kinase conformation.
Journal of medicinal chemistry, 53 7
-
D.
Tikhonov,
B.
Zhorov
(2012)
Architecture and Pore Block of Eukaryotic Voltage-Gated Sodium Channels in View of NavAb Bacterial Sodium Channel Structure
Molecular Pharmacology, 82
-
C.
Valant,
K.
Gregory,
N.
Hall,
P.
Scammells,
M.
Lew,
P.
Sexton,
A.
Christopoulos
(2008)
A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity
Journal of Biological Chemistry, 283
-
J.
Hall,
C.
Chang,
D.
McDonnell
(2000)
Development of peptide antagonists that target estrogen receptor beta-coactivator interactions.
Molecular endocrinology, 14 12
-
D.
Vanderpool,
Ted
Johnson,
Chen
Ping,
S.
Bergqvist,
G.
Alton,
Soneprasith
Phonephaly,
E.
Rui,
Chun
Luo,
Ya-li
Deng,
S.
Grant,
T.
Quenzer,
S.
Margosiak,
J.
Register,
E.
Brown,
J.
Ermolieff
(2009)
Characterization of the CHK1 allosteric inhibitor binding site.
Biochemistry, 48 41
-
Huixian
Wu,
Chong
Wang,
K.
Gregory,
K.
Gregory,
G.
Han,
Hyekyung
Cho,
Y.
Xia,
C.
Niswender,
V.
Katritch,
J.
Meiler,
V.
Cherezov,
P.
Conn,
R.
Stevens
(2014)
Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator
Science, 344
-
J.
Payandeh,
T.
El-Din,
T.
Scheuer,
Ning
Zheng,
W.
Catterall
(2012)
Crystal structure of a voltage-gated sodium channel in two potentially inactivated states
Nature, 486
-
Jean-Pierre
Changeux,
Jean
Thiéry,
Yvonne
Tung,
C.
Kittel
(1967)
On the cooperativity of biological membranes.
Proceedings of the National Academy of Sciences of the United States of America, 57 2
-
Xiaohua
Lou,
G.
Toresson,
Cindy
Benod,
J.
Suh,
Kevin
Philips,
P.
Webb,
J.
Gustafsson
(2014)
Structure of the retinoid X receptor α–liver X receptor β (RXRα–LXRβ) heterodimer on DNA
Nature Structural &Molecular Biology, 21
-
W.
Scheuer,
T.
Friess,
H.
Burtscher,
B.
Bossenmaier,
J.
Endl,
M.
Hasmann
(2009)
Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models.
Cancer research, 69 24
-
W.
Catterall,
S.
Cestèle,
V.
Yarov-Yarovoy,
F.
Yu,
K.
Konoki,
T.
Scheuer
(2007)
Voltage-gated ion channels and gating modifier toxins.
Toxicon : official journal of the International Society on Toxinology, 49 2
-
E.
Barnard,
P.
Skolnick,
R.
Olsen,
H.
Mohler,
W.
Sieghart,
G.
Biggio,
C.
Braestrup,
A.
Bateson,
S.
Langer
(1998)
International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function.
Pharmacological reviews, 50 2
-
L.
Sauguet,
R.
Howard,
Laurie
Malherbe,
Ui
Lee,
P.
Corringer,
R.
Harris,
M.
Delarue
(2013)
Structural basis for potentiation by alcohols and anaesthetics in a ligand-gated ion channel
Nature Communications, 4
-
A.
Converso,
Timothy
Hartingh,
R.
Garbaccio,
Edward
Tasber,
K.
Rickert,
M.
Fraley,
Youwei
Yan,
Constantine
Kreatsoulas,
S.
Stirdivant,
Bob
Drakas,
E.
Walsh,
K.
Hamilton,
C.
Buser,
Xianzhi
Mao,
M.
Abrams,
Stephen
Beck,
Weikang
Tao,
R.
Lobell,
L.
Sepp-Lorenzino,
J.
Zugay-Murphy,
V.
Sardana,
S.
Munshi,
Sylvie
Jezequel-Sur,
P.
Zuck,
G.
Hartman
(2009)
Development of thioquinazolinones, allosteric Chk1 kinase inhibitors.
Bioorganic & medicinal chemistry letters, 19 4
-
A.
Hsieh,
M.
Moasser
(2007)
Targeting HER proteins in cancer therapy and the role of the non-target HER3
British Journal of Cancer, 97
-
Guodong
Li,
D.
Chiara,
Jonathan
Cohen,
R.
Olsen
(2010)
Numerous Classes of General Anesthetics Inhibit Etomidate Binding to γ-Aminobutyric Acid Type A (GABAA) Receptors*
The Journal of Biological Chemistry, 285
-
T.
Anderson,
J.
Gordon,
S.
Garwood
(1988)
On the Application of R -Curves and Maximum Load Toughness to Structures
ASTM special technical publications
-
M.
Canals,
P.
Sexton,
A.
Christopoulos
(2011)
Allostery in GPCRs: 'MWC' revisited.
Trends in biochemical sciences, 36 12
-
M.
Roell,
H.
Issafras,
R.
Bauer,
K.
Michelson,
N.
Mendoza,
S.
Vanegas,
L.
Gross,
P.
Larsen,
Daniel
Bedinger,
D.
Bohmann,
G.
Nonet,
Naichi
Liu,
Steve
Lee,
M.
Handa,
S.
Kantak,
A.
Horwitz,
J.
Hunter,
A.
Owyang,
A.
Mirza,
J.
Corbin,
M.
White
(2010)
Kinetic Approach to Pathway Attenuation Using XOMA 052, a Regulatory Therapeutic Antibody That Modulates Interleukin-1β Activity
The Journal of Biological Chemistry, 285
-
F.
Yu,
W.
Catterall
(2004)
The VGL-Chanome: A Protein Superfamily Specialized for Electrical Signaling and Ionic Homeostasis
Science's STKE, 2004
-
Hyun-soo
Cho,
K.
Mason,
K.
Ramyar,
A.
Stanley,
S.
Gabelli,
D.
Denney,
D.
Leahy
(2003)
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
Nature, 421
-
Xuewu
Zhang,
Jodi
Gureasko,
Kui
Shen,
P.
Cole,
J.
Kuriyan
(2006)
An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor
Cell, 125
-
F.
Adrián,
Q.
Ding,
Taebo
Sim,
A.
Velentza,
C.
Sloan,
Yi
Liu,
Guobao
Zhang,
W.
Hur,
Sheng
Ding,
P.
Manley,
J.
Mestan,
D.
Fabbro,
N.
Gray
(2006)
Allosteric inhibitors of Bcr-abl–dependent cell proliferation
Nature Chemical Biology, 2
-
D.
Koshland,
G.
Némethy,
D.
Filmer
(1966)
Comparison of experimental binding data and theoretical models in proteins containing subunits.
Biochemistry, 5 1
-
M.
Liao,
E.
Cao,
D.
Julius,
Yifan
Cheng
(2013)
Structure of the TRPV1 ion channel determined by electron cryo-microscopy
Nature, 504
-
M.
Jackson
(1984)
Spontaneous openings of the acetylcholine receptor channel.
Proceedings of the National Academy of Sciences of the United States of America, 81 12
-
Anna
Chatzidaki,
N.
Millar
(2015)
Allosteric modulation of nicotinic acetylcholine receptors.
Biochemical pharmacology, 97 4
-
M.
Spedding
(1985)
Competitive interactions between Bay K 8644 and nifedipine in K+ depolarized smooth muscle: a passive role for Ca2+?
Naunyn-Schmiedeberg's Archives of Pharmacology, 328
-
S.
Lazareno,
V.
Dolezal,
A.
Popham,
N.
Birdsall
(2004)
Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.
Molecular pharmacology, 65 1
-
M.
Spedding,
A.
Mir
(1987)
Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand
British Journal of Pharmacology, 92
-
J.
Giezen,
L.
Nilsson,
P.
Berntsson,
Britt-Marie
Wissing,
F.
Giordanetto,
W.
Tomlinson,
P.
Greasley
(2009)
Ticagrelor binds to human P2Y12 independently from ADP but antagonizes ADP‐induced receptor signaling and platelet aggregation
Journal of Thrombosis and Haemostasis, 7
-
G.
Sawyer,
D.
Chiara,
R.
Olsen,
Jonathan
Cohen
(2002)
Identification of the bovine gamma-aminobutyric acid type A receptor alpha subunit residues photolabeled by the imidazobenzodiazepine [3H]Ro15-4513.
The Journal of biological chemistry, 277 51
-
E.
Bourinet,
T.
Soong,
K.
Sutton,
S.
Slaymaker,
E.
Mathews,
A.
Monteil,
G.
Zamponi,
J.
Nargeot,
T.
Snutch
(1999)
Splicing of alpha 1A subunit gene generates phenotypic variants of P- and Q-type calcium channels.
Nature neuroscience, 2 5
-
R.
Study,
J.
Barker
(1981)
Diazepam and (--)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons.
Proceedings of the National Academy of Sciences of the United States of America, 78 11
-
Peter
Keov,
P.
Sexton,
A.
Christopoulos
(2011)
Allosteric modulation of G protein-coupled receptors: A pharmacological perspective
Neuropharmacology, 60
-
Xu
Zhang,
W.
Ren,
P.
DeCaen,
Chuangye
Yan,
X.
Tao,
Lin
Tang,
Jingjing
Wang,
K.
Hasegawa,
T.
Kumasaka,
Jianhua
He,
Jiawei
Wang,
D.
Clapham,
N.
Yan
(2012)
Crystal structure of an orthologue of the NaChBac voltage-gated sodium channel
Nature, 486
-
A.
Clark,
F.
Mitchelson
(1976)
THE INHIBITORY EFFECT OF GALLAMINE ON MUSCARINIC RECEPTORS
British Journal of Pharmacology, 58
-
Ching-Yi
Chang,
J.
Abdo,
Tanya
Hartney,
D.
McDonnell
(2005)
Development of peptide antagonists for the androgen receptor using combinatorial peptide phage display.
Molecular endocrinology, 19 10
-
R.
Savkur,
T.
Burris
(2004)
The coactivator LXXLL nuclear receptor recognition motif.
The journal of peptide research : official journal of the American Peptide Society, 63 3
-
Annelien
Zweemer,
I.
Nederpelt,
H.
Vrieling,
Sarah
Hafith,
Maarten
Doornbos,
H.
Vries,
J.
Abt,
Raymond
Gross,
Dean
Stamos,
J.
Saunders,
M.
Smit,
A.
IJzerman,
L.
Heitman
(2013)
Multiple Binding Sites for Small-Molecule Antagonists at the CC Chemokine Receptor 2
Molecular Pharmacology, 84
-
J.
Hall,
Ching-Yi
Chang,
D.
McDonnell
(2000)
Development of Peptide Antagonists That Target Estrogen Receptor β-Coactivator Interactions
Molecular Endocrinology, 14
-
C.
Armstrong
(1981)
Sodium channels and gating currents.
Physiological reviews, 61 3
-
J.
Peters,
M.
Cooper,
J.
Carland,
M.
Livesey,
T.
Hales,
J.
Lambert
(2010)
Novel structural determinants of single channel conductance and ion selectivity in 5‐hydroxytryptamine type 3 and nicotinic acetylcholine receptors
The Journal of Physiology, 588
-
H.
Lüllmann,
F.
Ohnesorge,
G.
Schauwecker,
O.
Wassermann
(1969)
Inhibition of the actions of carbachol and DFP on guinea pig isolated atria by alkane-bis-ammonium compounds.
European journal of pharmacology, 6 3
-
T.
Kenakin,
L.
Miller
(2010)
Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery
Pharmacological Reviews, 62
-
T.
Moore,
C.
Mayne,
J.
Katzenellenbogen
(2010)
Minireview: Not picking pockets: nuclear receptor alternate-site modulators (NRAMs).
Molecular endocrinology, 24 4
-
J.
Castillo,
B.
Katz
(1957)
Interaction at end-plate receptors between different choline derivatives
Proceedings of the Royal Society of London. Series B - Biological Sciences, 146
-
M.
Lewis
(2005)
The lac repressor.
Comptes rendus biologies, 328 6
-
C.
Langmead,
A.
Christopoulos
(2014)
Functional and structural perspectives on allosteric modulation of GPCRs.
Current opinion in cell biology, 27
-
J.
Stockton,
N.
Birdsall,
A.
Burgen,
E.
Hulme
(1983)
Modification of the binding properties of muscarinic receptors by gallamine.
Molecular pharmacology, 23 3
-
R.
MacKinnon,
Christopher
Miller
(1989)
Mutant potassium channels with altered binding of charybdotoxin, a pore-blocking peptide inhibitor.
Science, 245 4924
-
B.
Li,
Y.
Liu,
T.
Uno,
N.
Gray
(2004)
Creating chemical diversity to target protein kinases.
Combinatorial chemistry & high throughput screening, 7 5
-
S.
Hansen,
P.
Taylor
(2007)
Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.
Journal of molecular biology, 369 4
-
D.
Matthews,
M.
Gerritsen
(2010)
Targeting Protein Kinases for Cancer Therapy
-
L.
Arnold,
E.
Estébanez-Perpiñá,
Marie
Togashi,
N.
Jouravel,
A.
Shelat,
A.
McReynolds,
Ellena
Mar,
P.
Nguyen,
John
Baxter,
R.
Fletterick,
P.
Webb,
R.
Guy
(2005)
Discovery of Small Molecule Inhibitors of the Interaction of the Thyroid Hormone Receptor with Transcriptional Coregulators*
Journal of Biological Chemistry, 280
-
H.
Issafras,
J.
Corbin,
I.
Goldfine,
M.
Roell
(2014)
Detailed Mechanistic Analysis of Gevokizumab, an Allosteric Anti–IL-1β Antibody with Differential Receptor-Modulating Properties
The Journal of Pharmacology and Experimental Therapeutics, 348
-
T.
Kenakin
(2009)
Interrogating 7TM receptors: Does texture in the question yield greater texture in the answer?
Journal of Receptors and Signal Transduction, 29
-
Y.
Li-Smerin,
Kenton
Swartz
(1998)
Gating modifier toxins reveal a conserved structural motif in voltage-gated Ca2+ and K+ channels.
Proceedings of the National Academy of Sciences of the United States of America, 95 15
-
S.
Traynelis,
L.
Wollmuth,
C.
McBain,
F.
Menniti,
Katie
Vance,
Kevin
Ogden,
K.
Hansen,
Hongjie
Yuan,
S.
Myers,
R.
Dingledine
(2010)
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Pharmacological Reviews, 62
-
V.
Yarov-Yarovoy,
P.
DeCaen,
R.
Westenbroek,
C.
Pan,
T.
Scheuer,
D.
Baker,
W.
Catterall
(2011)
Structural basis for gating charge movement in the voltage sensor of a sodium channel
Proceedings of the National Academy of Sciences, 109
-
Alberto
Bardelli,
Alberto
Bardelli,
D.
Parsons,
N.
Silliman,
J.
Ptak,
Steve
Szabo,
Saurabh
Saha,
S.
Markowitz,
J.
Willson,
G.
Parmigiani,
K.
Kinzler,
B.
Vogelstein,
V.
Velculescu
(2003)
Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers
Nature Reviews Cancer, 3
-
J.
Changeux
(2013)
50 years of allosteric interactions: the twists and turns of the models
Nature Reviews Molecular Cell Biology, 14
-
K.
Leach,
P.
Sexton,
A.
Christopoulos
(2007)
Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology.
Trends in pharmacological sciences, 28 8
-
K.
Inoki,
M.
Corradetti,
K.
Guan
(2004)
Dysregulation of the TSC-mTOR pathway in human disease
Nature Genetics, 37
-
H.
Hanchar,
Panida
Chutsrinopkun,
P.
Meera,
P.
Supavilai,
W.
Sieghart,
M.
Wallner,
R.
Olsen
(2006)
Ethanol potently and competitively inhibits binding of the alcohol antagonist Ro15-4513 to alpha4/6beta3delta GABAA receptors.
Proceedings of the National Academy of Sciences of the United States of America, 103 22
-
A.
Taly,
P.
Corringer,
D.
Guédin,
P.
Lestage,
J.
Changeux
(2009)
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
Nature Reviews Drug Discovery, 8
-
Scott
Downing,
Y.
Lee,
D.
Farb,
T.
Gibbs
(2005)
Benzodiazepine modulation of partial agonist efficacy and spontaneously active GABAA receptors supports an allosteric model of modulation
British Journal of Pharmacology, 145
-
G.
Hockerman,
Blaise
Peterson,
Elizabeth
Sharp,
T.
Tanada,
T.
Scheuer,
W.
Catterall
(1997)
Construction of a high-affinity receptor site for dihydropyridine agonists and antagonists by single amino acid substitutions in a non-L-type Ca2+ channel.
Proceedings of the National Academy of Sciences of the United States of America, 94 26
-
Daya
Perkins,
J.
Trudell,
D.
Crawford,
L.
Asatryan,
R.
Alkana,
D.
Davies
(2009)
Loop 2 Structure in Glycine and GABAA Receptors Plays a Key Role in Determining Ethanol Sensitivity*
The Journal of Biological Chemistry, 284
-
Fan
Gao,
P.
Sexton,
A.
Christopoulos,
L.
Miller
(2008)
Benzodiazepine ligands can act as allosteric modulators of the Type 1 cholecystokinin receptor.
Bioorganic & medicinal chemistry letters, 18 15
-
J.
Lindberg,
B.
Culleton,
Gordon
Wong,
M.
Borah,
R.
Clark,
W.
Shapiro,
S.
Roger,
F.
Husserl,
P.
Klassen,
M.
Guo,
Moetaz
Albizem,
J.
Coburn
(2005)
Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study.
Journal of the American Society of Nephrology : JASN, 16 3
-
R.
Stephenson
(1997)
A MODIFICATION OF RECEPTOR THEORY
British Journal of Pharmacology, 120
-
W.
Catterall,
K.
Chandy,
D.
Clapham,
G.
Gutman,
Franz
Hofmann,
A.
Harmar,
D.
Abernethy,
M.
Spedding
(2003)
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Pharmacological Reviews, 55
-
T.
Kenakin,
A.
Christopoulos
(2012)
Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Nature Reviews Drug Discovery, 12
-
R.
Olsen,
Sapp
Dw
(1995)
Neuroactive steroid modulation of GABAA receptors.
Advances in biochemical psychopharmacology, 48
-
D.
Udugamasooriya,
S.
Dineen,
R.
Brekken,
T.
Kodadek
(2008)
A peptoid "antibody surrogate" that antagonizes VEGF receptor 2 activity.
Journal of the American Chemical Society, 130 17
-
W.
Chan,
D.
McKinzie,
S.
Bose,
S.
Mitchell,
J.
Witkin,
R.
Thompson,
A.
Christopoulos,
S.
Lazareno,
Nigel
Birdsall,
F.
Bymaster,
Christian
Felder
(2008)
Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia
Proceedings of the National Academy of Sciences, 105
-
Geoffrey
Smith,
R.
Olsen
(1995)
Functional domains of GABAA receptors.
Trends in pharmacological sciences, 16 5
-
S.
Hoare,
Beth
Fleck,
R.
Gross,
P.
Crowe,
J.
Williams,
D.
Grigoriadis
(2008)
Allosteric Ligands for the Corticotropin Releasing Factor Type 1 Receptor Modulate Conformational States Involved in Receptor Activation
Molecular Pharmacology, 73
-
M.
SPEDDING1,
R.
PAOLETTI2,
R.
Pao,
J.
Nueten,
P.
Zwieten
(2005)
III. Classification of Calcium Channels and the Sites of Action of Drugs Modifying Channel Function
-
V.
Chandra,
Pengxiang
Huang*,
N.
Potluri,
Dalei
Wu,
Youngchang
Kim,
F.
Rastinejad
(2013)
Multi-Domain Integration in the Structure of the HNF4α Nuclear Receptor Complex
Nature, 495
-
J.
Grimsby,
R.
Sarabu,
W.
Corbett,
N.
Haynes,
F.
Bizzarro,
J.
Coffey,
K.
Guertin,
Darryl
Hilliard,
R.
Kester,
P.
Mahaney,
Linda
Marcus,
L.
Qi,
Cheryl
Spence,
J.
Tengi,
M.
Magnuson,
C.
Chu,
M.
Dvorozniak,
F.
Matschinsky,
J.
Grippo
(2003)
Allosteric Activators of Glucokinase: Potential Role in Diabetes Therapy
Science, 301
-
D.
Scholten,
M.
Canals,
D.
Maussang,
L.
Roumen,
M.
Smit,
M.
Wijtmans,
C.
Graaf,
H.
Vischer,
R.
Leurs
(2012)
Pharmacological modulation of chemokine receptor function
British Journal of Pharmacology, 165
-
A.
Kruse,
A.
Ring,
A.
Manglik,
Jianxin
Hu,
Kelly
Hu,
K.
Eitel,
H.
Hübner,
E.
Pardon,
C.
Valant,
P.
Sexton,
A.
Christopoulos,
C.
Felder,
P.
Gmeiner,
J.
Steyaert,
W.
Weis,
K.
Garcia,
J.
Wess,
B.
Kobilka
(2013)
Activation and allosteric modulation of a muscarinic acetylcholine receptor
Nature, 504
-
M.
Canals,
J.
Lane,
Adriel
Wen,
P.
Scammells,
P.
Sexton,
A.
Christopoulos
(2011)
A Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric Modulation*
The Journal of Biological Chemistry, 287
-
Jungwon
Choi,
Jie
Chen,
S.
Schreiber,
J.
Clardy
(1996)
Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP
Science, 273